PhaseBio Expands Executive Management Team
PhaseBio Pharmaceuticals, Inc. (PHAS)
Last phasebio pharmaceuticals, inc. earnings: 3/30 08:01 am
Check Earnings Report
Company Research
Source: GlobeNewswire
MALVERN, Pa. and SAN DIEGO, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the expansion of its executive management team with the appointment of Kristopher L. Hanson as Vice President, Head of Legal and Glen Burkhardt as Vice President of Human Resources. “PhaseBio has achieved critical milestones this year and is making solid progress in the advancement of PB2452, a novel agent for the reversal of the antiplatelet activity of ticagrelor,” said Jonathan P. Mow, Chief Executive Officer of PhaseBio. “These additions to our management team allow us to more efficiently prepare for the submission of a Biologics License Application for PB2452 and for potential accelerated approval and commercial launch. We are delighted to welcome Kris and Glen, two seasoned leaders with extensive biopharmac
Show less
Read more
Impact Snapshot
Event Time:
PHAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHAS alerts
High impacting PhaseBio Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics